Filter
1571
Filtered Results: 1571
Text search:
human
pharmaceutical
products
Featured
Recommendations
147
New Publications
452
Language
Document type
No document type
824
Studies & Reports
302
Guidelines
229
Manuals
80
Strategic & Response Plan
78
Fact sheets
21
Training Material
18
Situation Updates
11
Resource Platforms
4
Infographics
2
Brochures
1
Online Courses
1
Countries / Regions
Kenya
66
Ethiopia
57
Global
55
India
51
Nigeria
35
South Africa
34
Sierra Leone
33
Western and Central Europe
32
Liberia
30
Uganda
30
Rwanda
27
Ghana
25
Nepal
25
Namibia
25
Zambia
23
Tanzania
23
Philippines
19
Ukraine
19
Malawi
18
Africa
17
Bangladesh
16
Indonesia
13
Lesotho
13
Latin America and the Carribbean
13
Eastern Europe
13
Zimbabwe
12
Myanmar / Burma
12
Cambodia
11
South–East Asia Region
11
Eswatini/ Swaziland
10
Syria
9
Botswana
9
West and Central Africa
9
East and Southern Africa
8
Eastern Europe and Central Asia
8
Guinea
6
Burkina Faso
6
Congo, Democratic Republic of
6
Asia
6
Haiti
5
South Sudan
5
Senegal
4
Cameroon
4
Pakistan
4
Middle East and North Africa
4
Venezuela
4
Albania
4
USA
3
Jordan
3
Thailand
3
China
3
Mozambique
3
Sudan
3
North Macedonia
3
Western Pacific Region
3
Fiji
3
Laos
3
Russia
3
North America
3
Mali
2
Afghanistan
2
Germany
2
Lebanon
2
Egypt
2
Papua New Guinea
2
Benin
2
Central African Republic
2
Peru
2
Brazil
2
Serbia
2
Southern Africa
2
Tajikistan
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Ireland
1
Ecuador
1
Libya
1
Angola
1
Madagascar
1
Sri Lanka
1
Yemen
1
Bhutan
1
Armenia
1
Timor Leste/ East Timor
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
630
Clinical Guidelines
113
Public Health
87
Key Resources
62
Women & Child Health
42
Pharmacy & Technologies
23
Capacity Building
10
Annual Report MEDBOX
1
Toolboxes
AMR
175
Pharmacy
145
COVID-19
103
TB
76
Mental Health
70
HIV
69
Rapid Response
54
Planetary Health
52
Global Health Education
37
NTDs
37
Caregiver
29
NCDs
28
Conflict
27
Ebola
26
Health Financing Toolbox
23
Specific Hazards
13
Disability
10
Refugee
10
Polio
8
Natural Hazards
8
Zika
3
Social Ethics
3
Cholera
1
Health Financing
1
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
The present National action plan on antimicrobial resistance (AMR) with component of antimicrobial consumption (AMC) covering both human and agriculture sectors was developed based on the World Health Organization's (WHO) Global plan on AMR dated 20...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L...
"National Disaster Management Guidelines: Management
of Chemical (Terrorism) Disasters (are intended to
focus on all aspects of the disaster management
cycle, including prevention measures such as
surveillance and intelligence, mitigation of direct
and indirect risks, preparedness in terms of
...
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
Through public-private partnerships, the government of Rwanda can make more efficient use of public resources by targeting and meeting the needs of specific populations and thus help ensure family planning services and products will be available to ...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities and utilities
should always be properly designed, bu...
The Central African Republic is at a major turning point in its history. The country
is just emerging from a very violent conflict, during which thousands of human lives were lost and one-third of the population was displaced. After
a three-year t...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and ... Services (MTaPS) Program; and WHO that are committed to ensuring that the transmission of COVID-19 to HCWs and the public within the health care setting is limited. The Ministry of Health (MOH) through the Directorate of Health Standards Quality Assurance and Regulations wishes to thank all the contributing authors led by the sub-committee on case management and IPC for the COVID-19 response for their expertise and time given to writing these guidelines.
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
At a time when the world is reeling from the deepest global disruption and health crisis of a lifetime, this year’s Living Planet
report provides unequivocal and alarming evidence that nature is unraveling and that our planet is flashing red warning signs of
vital natural systems failure. The ...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in ...ion animals – Cattle and Pigs, were accepted. By decision of the board of the Swedish Veterinary Society (SVS) these guidelines have been updated. Th e over-arching goal of SVS is to achieve a low and controlled use of antibiotics in Swedish animal production so that the fi rst-hand choices of treatment remain effi cient and that the spread of antimicrobial resistance – among animals and herds as well as in the food chain – is kept at a minimum. Keeping antimicrobial resistance in animals low is important also for human health, since we are all part of the same ecosystem. Th e authors of these guidelines hope that they may be useful for veteri-narians in clinical practice when deciding on treatments for common diseases and ailments caused by bacteria. Sometimes the decision may even be to refrain from use of antibiotics and chose other ways of improving herd health.
